WuXi AppTec Balance Sheet Health
Financial Health criteria checks 5/6
WuXi AppTec has a total shareholder equity of CN¥55.1B and total debt of CN¥5.8B, which brings its debt-to-equity ratio to 10.5%. Its total assets and total liabilities are CN¥74.4B and CN¥19.3B respectively. WuXi AppTec's EBIT is CN¥9.5B making its interest coverage ratio -20.7. It has cash and short-term investments of CN¥14.7B.
Key information
10.5%
Debt to equity ratio
CN¥5.81b
Debt
Interest coverage ratio | -20.7x |
Cash | CN¥14.67b |
Equity | CN¥55.09b |
Total liabilities | CN¥19.30b |
Total assets | CN¥74.40b |
Recent financial health updates
These 4 Measures Indicate That WuXi AppTec (SHSE:603259) Is Using Debt Reasonably Well
Jul 12WuXi AppTec (SHSE:603259) Has A Pretty Healthy Balance Sheet
Apr 09Recent updates
Benign Growth For WuXi AppTec Co., Ltd. (SHSE:603259) Underpins Its Share Price
Jul 30These 4 Measures Indicate That WuXi AppTec (SHSE:603259) Is Using Debt Reasonably Well
Jul 12WuXi AppTec (SHSE:603259) Has Announced That It Will Be Increasing Its Dividend To CN¥0.9897
Jun 23We Think Some Shareholders May Hesitate To Increase WuXi AppTec Co., Ltd.'s (SHSE:603259) CEO Compensation
Jun 05WuXi AppTec (SHSE:603259) Has A Pretty Healthy Balance Sheet
Apr 09WuXi AppTec Co., Ltd. (SHSE:603259) Analysts Just Slashed This Year's Estimates
Mar 23Benign Growth For WuXi AppTec Co., Ltd. (SHSE:603259) Underpins Its Share Price
Mar 01Financial Position Analysis
Short Term Liabilities: 603259's short term assets (CN¥30.3B) exceed its short term liabilities (CN¥13.6B).
Long Term Liabilities: 603259's short term assets (CN¥30.3B) exceed its long term liabilities (CN¥5.7B).
Debt to Equity History and Analysis
Debt Level: 603259 has more cash than its total debt.
Reducing Debt: 603259's debt to equity ratio has increased from 7.2% to 10.5% over the past 5 years.
Debt Coverage: 603259's debt is well covered by operating cash flow (217.1%).
Interest Coverage: 603259 earns more interest than it pays, so coverage of interest payments is not a concern.